Technical information
		                    	
		                    
		                    
		                    
		                    	
			                    	Manufacturer
			                    	AOP ORPHAN PHARMACEUTICALS AG
			                     
		                    	
		                   
			                   
			                    	Presentation
			                    	
 
 
  
   ANAGRELIDE AOP 0,5 mg, gélule
     B/100 - Code CIP : 34009 301482 2 8
   
 
 
			                     
		                    
	                     
	                    
	                    
	                    
	
                	 
               	 
                
             
         
     
	
        
  
			
		
	
	
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
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
GefuSHhN6PQdw0KN